BURACCHI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.349
AS - Asia 1.872
EU - Europa 1.196
SA - Sud America 323
AF - Africa 56
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.803
Nazione #
US - Stati Uniti d'America 2.249
SG - Singapore 710
CN - Cina 333
IT - Italia 321
HK - Hong Kong 271
BR - Brasile 238
VN - Vietnam 209
RU - Federazione Russa 199
DE - Germania 137
IE - Irlanda 116
SE - Svezia 100
CA - Canada 72
FR - Francia 66
IN - India 66
GB - Regno Unito 60
BD - Bangladesh 46
FI - Finlandia 40
AR - Argentina 34
ES - Italia 33
ID - Indonesia 32
NL - Olanda 27
KR - Corea 26
PH - Filippine 24
TR - Turchia 24
SA - Arabia Saudita 23
IQ - Iraq 22
JP - Giappone 19
UA - Ucraina 19
ZA - Sudafrica 19
PK - Pakistan 17
CH - Svizzera 14
MX - Messico 14
PL - Polonia 14
AT - Austria 11
EC - Ecuador 10
VE - Venezuela 10
CO - Colombia 9
ET - Etiopia 8
CL - Cile 7
IL - Israele 7
PE - Perù 7
MA - Marocco 6
AU - Australia 5
BE - Belgio 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
GR - Grecia 5
JO - Giordania 5
KE - Kenya 5
MY - Malesia 5
PY - Paraguay 5
RS - Serbia 5
UZ - Uzbekistan 5
AL - Albania 4
LT - Lituania 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
LK - Sri Lanka 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
TN - Tunisia 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
JM - Giamaica 2
KG - Kirghizistan 2
MU - Mauritius 2
SN - Senegal 2
UY - Uruguay 2
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MZ - Mozambico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.803
Città #
Singapore 403
Ann Arbor 397
Ashburn 277
Hong Kong 264
San Jose 206
Dublin 112
New York 93
Milan 80
Chandler 75
Frankfurt am Main 66
Hefei 64
Los Angeles 63
Chicago 60
Fairfield 59
Beijing 57
Ho Chi Minh City 57
Dallas 54
Santa Clara 50
Hanoi 46
Toronto 39
Wilmington 35
The Dalles 32
Woodbridge 31
Lauterbourg 30
Seattle 29
Houston 27
Buffalo 25
Seoul 25
Munich 24
Shanghai 23
Helsinki 22
Council Bluffs 21
Lissone 21
Princeton 20
Denver 19
Orem 19
Moscow 18
Jakarta 17
São Paulo 17
Cambridge 16
Tokyo 16
Pune 15
Amsterdam 14
London 14
Nuremberg 14
San Francisco 14
Warsaw 14
Johannesburg 13
Rome 13
Brooklyn 12
Da Nang 12
Dhaka 12
Turku 12
Zurich 12
Belo Horizonte 11
Montreal 11
Atlanta 10
Fremont 10
Haiphong 10
Lawrence 10
Stockholm 10
Florence 9
Addis Ababa 8
Altamura 8
Dong Ket 8
Genoa 8
Jeddah 8
Poplar 8
Rio de Janeiro 8
Chennai 7
Guangzhou 7
Riyadh 7
Ankara 6
Baghdad 6
Brescia 6
City of London 6
Curitiba 6
Dammam 6
Desio 6
Istanbul 6
Lappeenranta 6
Biên Hòa 5
Boston 5
Brussels 5
Charlotte 5
Dearborn 5
Düsseldorf 5
Garbagnate Milanese 5
Kent 5
Kyiv 5
Lima 5
Nairobi 5
Phoenix 5
Turin 5
Vienna 5
Barnet 4
Beauharnois 4
Brno 4
Contursi 4
Elk Grove Village 4
Totale 3.482
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 427
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 419
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 302
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia 280
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 276
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 270
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 260
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 228
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 228
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia 222
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 222
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 183
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 182
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 176
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 170
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 170
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 164
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels 149
Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion 143
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family 130
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study 125
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 118
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study 117
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia 106
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia 105
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study 104
Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin 103
The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice 98
Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: Selective upregulation by rapamycin 91
Increased inflammation in mice deficient for the chemokine decoy receptor D6 91
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment 84
Control of murine Ly6Chigh monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6 79
Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study 51
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma 47
Totale 5.920
Categoria #
all - tutte 20.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.775


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 38 38
2021/2022257 31 39 31 19 17 23 5 10 24 19 17 22
2022/2023373 31 82 34 22 4 36 14 79 37 2 21 11
2023/2024438 13 8 17 45 55 109 91 10 25 14 4 47
2024/20251.103 45 122 44 55 101 32 58 17 109 168 117 235
2025/20263.159 430 182 228 424 435 178 468 160 280 297 77 0
Totale 5.920